Media coverage about Ceres (NASDAQ:CERE) has trended somewhat positive on Tuesday, according to Accern. The research firm identifies positive and negative news coverage by monitoring more than 20 million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. Ceres earned a news sentiment score of 0.06 on Accern’s scale. Accern also assigned news stories about the biotechnology company an impact score of 44.6003712959445 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the immediate future.
Ceres (NASDAQ:CERE) remained flat at $$0.40 during mid-day trading on Tuesday. 182,300 shares of the company traded hands, compared to its average volume of 848,868. Ceres has a 52 week low of $0.16 and a 52 week high of $4.80.
WARNING: “Ceres (CERE) Receives Daily News Sentiment Rating of 0.06” was originally published by The Ledger Gazette and is the property of of The Ledger Gazette. If you are viewing this report on another website, it was illegally copied and republished in violation of U.S. and international copyright law. The original version of this report can be accessed at https://ledgergazette.com/2017/12/13/ceres-cere-given-daily-coverage-optimism-rating-of-0-06.html.
Ceres, Inc is an agricultural biotechnology company that develops and markets seeds and traits to produce crops for feed, forages, sugar and other markets. The Company uses a combination of plant breeding, biotechnology and bioinformatics to develop seed products and biotechnology traits. Its Forage sorghum seeds are used for growing feed for livestock, including dairy and beef cattle.
Receive News & Ratings for Ceres Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ceres and related companies with MarketBeat.com's FREE daily email newsletter.